Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 111,888 Cr
P/E 31.30
Div Yield 0.94 %
Book Value βΉ426.00
52w High βΉ1,673.00
52w Low βΉ1,166.00
Face Value βΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
7,119.00
6,541.00
7,074.00
7,589.00
6,957.00
6,730.00
7,073.00
7,051.00
6,694.00
6,163.00
6,604.00
6,678.00
6,329.00
Expenses
5,927.00
5,586.00
5,819.00
5,695.00
5,179.00
5,192.00
5,084.00
5,165.00
4,978.00
4,847.00
4,856.00
4,944.00
4,835.00
Operating Profit
1,192.00
955.00
1,255.00
1,895.00
1,778.00
1,538.00
1,989.00
1,886.00
1,716.00
1,316.00
1,748.00
1,734.00
1,494.00
OPM %
17.00
15.00
18.00
25.00
26.00
23.00
28.00
27.00
26.00
21.00
26.00
26.00
24.00
Other Income
211.00
148.00
-70.00
269.00
259.00
289.00
222.00
191.00
160.00
249.00
-10.00
176.00
136.00
Depreciation
304.00
383.00
278.00
297.00
253.00
309.00
280.00
272.00
247.00
288.00
233.00
290.00
239.00
Interest
17.00
13.00
14.00
13.00
14.00
14.00
15.00
15.00
18.00
18.00
30.00
26.00
16.00
Profit before tax
1,082.00
707.00
893.00
1,854.00
1,770.00
1,504.00
1,916.00
1,789.00
1,611.00
1,259.00
1,474.00
1,594.00
1,375.00
Tax %
27.00
22.00
24.00
27.00
27.00
19.00
17.00
27.00
27.00
26.00
28.00
28.00
28.00
Net Profit
786.00
543.00
674.00
1,353.00
1,292.00
1,214.00
1,575.00
1,305.00
1,175.00
932.00
1,068.00
1,155.00
998.00
EPS in Rs
9.77
6.87
8.37
16.73
16.06
15.13
19.45
16.13
14.58
11.63
13.08
14.01
12.33
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
28,163.00 27,548.00 25,774.00 22,753.00 21,763.00 19,160.00 17,132.00 16,362.00 15,156.00 14,394.00 13,790.00 11,345.00
Expenses
22,280.00 20,420.00 19,483.00 17,726.00 17,211.00 14,907.00 13,926.00 13,265.00 12,329.00 11,898.00 11,310.00 9,183.00
Operating Profit
5,883.00 7,128.00 6,291.00 5,027.00 4,553.00 4,252.00 3,206.00 3,097.00 2,826.00 2,496.00 2,480.00 2,163.00
OPM %
21.00 26.00 24.00 22.00 21.00 22.00 19.00 19.00 19.00 17.00 18.00 19.00
Other Income
606.00 862.00 552.00 293.00 99.00 266.00 344.00 477.00 280.00 208.00 208.00 164.00
Interest
54.00 62.00 90.00 110.00 106.00 161.00 197.00 168.00 114.00 159.00 207.00 168.00
Depreciation
1,211.00 1,107.00 1,051.00 1,172.00 1,052.00 1,068.00 1,175.00 1,326.00 1,323.00 1,323.00 754.00 505.00
Profit before tax
5,224.00 6,821.00 5,702.00 4,038.00 3,493.00 3,290.00 2,178.00 2,079.00 1,669.00 1,222.00 1,727.00 1,654.00
Tax %
26.00 22.00 27.00 30.00 27.00 27.00 29.00 27.00 15.00 15.00 19.00 24.00
Net Profit
3,862.00 5,269.00 4,154.00 2,833.00 2,547.00 2,389.00 1,500.00 1,492.00 1,417.00 1,035.00 1,383.00 1,229.00
EPS in Rs
48.02 65.28 51.05 34.71 31.19 29.82 19.18 18.96 17.52 12.51 16.93 14.71
Dividend Payout %
27.00 25.00 25.00 24.00 16.00 17.00 21.00 16.00 17.00 16.00 12.00 14.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
162.00 162.00 161.00 161.00 161.00 161.00 161.00 161.00 161.00 161.00 161.00 161.00
Reserves
34,270.00 31,032.00 26,545.00 23,246.00 20,680.00 18,165.00 15,602.00 14,851.00 14,068.00 12,383.00 11,356.00 10,641.00
Borrowings
614.00 438.00 559.00 803.00 1,056.00 2,014.00 2,816.00 4,316.00 4,098.00 4,113.00 5,202.00 1,703.00
Other Liabilities
7,297.00 5,702.00 5,267.00 5,089.00 4,960.00 4,514.00 4,843.00 4,433.00 4,346.00 4,213.00 4,331.00 3,166.00
Total Liabilities
42,343.00 37,334.00 32,533.00 29,300.00 26,857.00 24,855.00 23,423.00 23,762.00 22,673.00 20,869.00 21,049.00 15,670.00
Fixed Assets
12,434.00 10,006.00 9,607.00 9,160.00 9,683.00 9,516.00 9,683.00 9,608.00 9,950.00 9,492.00 9,368.00 6,830.00
CWIP
2,042.00 1,566.00 1,153.00 1,093.00 766.00 969.00 825.00 676.00 981.00 1,683.00 2,061.00 581.00
Investments
8,223.00 7,933.00 5,449.00 3,662.00 2,551.00 2,710.00 1,471.00 2,554.00 1,259.00 973.00 759.00 640.00
Other Assets
19,643.00 17,828.00 16,323.00 15,384.00 13,857.00 11,661.00 11,444.00 10,923.00 10,483.00 8,721.00 8,862.00 7,620.00
Total Assets
42,343.00 37,334.00 32,533.00 29,300.00 26,857.00 24,855.00 23,423.00 23,762.00 22,673.00 20,869.00 21,049.00 15,670.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
3,940.00 5,005.00 4,134.00 3,238.00 3,326.00 3,755.00 3,068.00 1,691.00 1,463.00 2,382.00 1,741.00 1,173.00
Cash from Investing Activity
-2,234.00 -3,682.00 -2,982.00 -2,376.00 -1,858.00 -2,374.00 114.00 -1,688.00 -834.00 -1,304.00 -4,533.00 -950.00
Cash from Financing Activity
-1,234.00 -1,293.00 -1,200.00 -958.00 -1,600.00 -1,240.00 -2,949.00 -349.00 -385.00 -1,326.00 3,104.00 165.00
Net Cash Flow
473.00 30.00 -49.00 -97.00 -132.00 141.00 234.00 -345.00 243.00 -248.00 312.00 388.00
Free Cash Flow
928.00 3,490.00 2,819.00 2,102.00 2,645.00 2,964.00 2,083.00 1,187.00 723.00 1,284.00 688.00 548.00
CFO/OP %
94.00 94.00 91.00 90.00 98.00 113.00 122.00 74.00 77.00 113.00 91.00 72.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
73.00 73.00 68.00 65.00 57.00 66.00 83.00 93.00 75.00 65.00 62.00 64.00
Inventory Days
252.00 231.00 217.00 228.00 230.00 232.00 267.00 250.00 271.00 239.00 273.00 329.00
Days Payable
123.00 116.00 102.00 112.00 108.00 103.00 139.00 123.00 142.00 108.00 106.00 126.00
Cash Conversion Cycle
202.00 188.00 182.00 181.00 180.00 195.00 211.00 220.00 204.00 196.00 230.00 267.00
Working Capital Days
106.00 128.00 120.00 113.00 95.00 94.00 113.00 132.00 118.00 99.00 -10.00 89.00
ROCE %
15.00 23.00 23.00 18.00 17.00 17.00 12.00 11.00 9.00 7.00 13.00 15.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
29.22
29.22
29.22
29.22
29.19
29.20
29.19
30.93
30.91
33.46
33.46
33.46
FIIs
20.20
22.55
23.93
24.54
25.24
26.28
26.65
28.80
27.82
25.82
25.73
25.74
DIIs
34.35
31.71
30.45
29.98
28.98
27.89
27.49
23.95
24.66
24.15
24.05
23.90
Public
15.93
16.26
16.12
15.99
16.30
16.36
16.43
16.11
16.40
16.36
16.53
16.68
No. of Shareholders
578,679
584,217
540,521
534,587
549,655
543,420
525,114
470,234
463,569
436,154
425,731
426,863
Corporate Actions
30 records
Back to all stocks